阿瓦諾斯醫療公司
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership132,735 shares
Latest Disclosed Value $ 1,859,617
UBS Group AG ownership in AVNS / Avanos Medical, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 132,735 shares of Avanos Medical, Inc. (US:AVNS) valued at $1,859,617 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 415,107 shares of Avanos Medical, Inc.. This represents a change in shares of -68.02% during the quarter. The current value of the position is $3,326,339 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (AVNS) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVNS / Avanos Medical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AVANOS MED COM 05350V106 132,735 -282,372 -68.02 1,860 -60.12 0.0001
2026-01-29 2025-12-31 13F AVANOS MED COM 05350V106 415,107 30,290 7.87 4,662 4.79 0.0001
2025-11-13 2025-09-30 13F AVANOS MED COM 05350V106 384,817 156,386 68.46 4,448 59.14 0.0007
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 228,431 77,808 51.66 2,796 29.52 0.0005
2025-05-13 2025-03-31 13F AVANOS MED COM 05350V106 150,623 35,747 31.12 2,158 18.05 0.0004
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 114,876 12,705 12.44 1,829 -25.54 0.0003
2024-11-14 2024-09-30 13F AVANOS MED COM 05350V106 102,171 48,402 90.02 2,455 129.23 0.0005
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 53,769 -25,990 -32.59 1,071 -32.56 0.0003
2024-05-13 2024-03-31 13F AVANOS MED COM 05350V106 79,759 26,979 51.12 1,588 34.23 0.0004
2024-02-09 2023-12-31 13F AVANOS MED COM 05350V106 52,780 22,167 72.41 1,184 91.42 0.0004
2023-11-09 2023-09-30 13F AVANOS MED COM 05350V106 30,613 -99,282 -76.43 619 -81.39 0.0002
2023-08-11 2023-06-30 13F AVANOS MED COM 05350V106 129,895 66,333 104.36 3,320 75.66 0.0011
2023-05-12 2023-03-31 13F AVANOS MED COM 05350V106 63,562 40,560 176.33 1,890 203.86 0.0007
2023-02-08 2022-12-31 13F AVANOS MED COM 05350V106 23,002 -96 -0.42 622 23.66 0.0002
2022-11-10 2022-09-30 13F AVANOS MED COM 05350V106 23,098 15,234 193.72 503 133.95 0.0002
2022-08-10 2022-06-30 13F AVANOS MED COM 05350V106 7,864 -17,913 -69.49 215 -75.09 0.0001
2022-05-16 2022-03-31 13F AVANOS MED COM 05350V106 25,777 14,185 122.37 863 114.68 0.0003
2022-02-14 2021-12-31 13F AVANOS MED COM 05350V106 11,592 1,806 18.45 402 31.80 0.0001
2021-11-15 2021-09-30 13F AVANOS MED COM 05350V106 9,786 -1,187 -10.82 305 -23.56 0.0001
2021-08-13 2021-06-30 13F AVANOS MED COM 05350V106 10,973 -15,641 -58.77 399 -65.72 0.0001
2021-05-12 2021-03-31 13F AVANOS MED COM 05350V106 26,614 16,420 161.08 1,164 148.72 0.0004
2021-02-11 2020-12-31 13F AVANOS MED COM 05350V106 10,194 -1,269 -11.07 468 22.83 0.0002
2020-11-12 2020-09-30 13F AVANOS MED COM 05350V106 11,463 142 1.25 381 14.41 0.0001
2020-07-31 2020-06-30 13F AVANOS MED COM 05350V106 11,321 -533 -4.50 333 4.39 0.0001
2020-05-01 2020-03-31 13F AVANOS MED COM 05350V106 11,854 994 9.15 319 -12.84 0.0002
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 10,860 -1,342 -11.00 366 -19.91 0.0001
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 12,202 -14,780 -54.78 457 -61.17 0.0002
2019-08-14 2019-06-30 13F AVANOS MED COM 05350V106 26,982 -28,917 -51.73 1,177 -50.65 0.0005
2019-05-14 2019-03-31 13F AVANOS MED COM 05350V106 55,899 26,173 88.05 2,385 79.19 0.0010
2019-02-14 2018-12-31 13F AVANOS MED COM 05350V106 29,726 -60,003 -66.87 1,331 -78.35 0.0006
2018-11-14 2018-09-30 13F AVANOS MED COM 05350V106 89,729 27,802 44.89 6,147 73.40 0.0024
2018-08-14 2018-06-30 13F HALYARD HEALTH COM 40650V100 61,927 -37,066 -37.44 3,545 -22.29 0.0015
2018-05-15 2018-03-31 13F HALYARD HEALTH COM 40650V100 98,993 39,728 67.03 4,562 66.68 0.0020
2018-02-14 2017-12-31 13F HALYARD HEALTH COM 40650V100 59,265 -12,253 -17.13 2,737 -15.03 0.0011
2017-11-14 2017-09-30 13F HALYARD HEALTH COM 40650V100 71,518 -35,609 -33.24 3,221 -23.46 0.0015
2017-11-14 2017-06-30 13F/A-1 HALYARD HEALTH COM 40650V100 107,127 9,542 9.78 4,208 13.21 0.0022
2017-08-14 2017-06-30 13F HALYARD HEALTH COM 40650V100 107,127 9,542 4,208
2017-11-14 2017-03-31 13F/A-1 HALYARD HEALTH COM 40650V100 97,585 23,819 32.29 3,717 36.25 0.0020
2017-05-12 2017-03-31 13F HALYARD HEALTH COM 40650V100 97,585 23,819 3,717
2017-02-14 2016-12-31 13F HALYARD HEALTH COM 40650V100 73,766 10,393 16.40 2,728 24.23 0.0015
2016-11-14 2016-09-30 13F HALYARD HEALTH COM 40650V100 63,373 -30,966 -32.82 2,196 -28.40 0.0013
2016-08-12 2016-06-30 13F HALYARD HEALTH COM 40650V100 94,339 -9,517 -9.16 3,067 2.82 0.0019
2016-05-12 2016-03-31 13F HALYARD HEALTH COM 40650V100 103,856 -24,521 -19.10 2,983 -30.45 0.0020
2016-02-16 2015-12-31 13F HALYARD HEALTH COM 40650V100 128,377 -82,640 -39.16 4,289 -28.53 0.0028
2015-11-13 2015-09-30 13F HALYARD HEALTH COM 40650V100 211,017 -31,730 -13.07 6,001 -38.96 0.0042
2015-08-14 2015-06-30 13F HALYARD HEALTH COM 40650V100 242,747 41,714 20.75 9,832 -0.60 0.0065
2015-05-14 2015-03-31 13F HALYARD HEALTH COM 40650V100 201,033 -23,388 -10.42 9,891 -3.08 0.0068
2015-02-17 2014-12-31 13F HALYARD HEALTH COM 40650V100 224,421 224,421 10,205 0.0071
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-14 2015-03-31 13F HALYARD HEALTH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F HALYARD HEALTH COM Put 300 14 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.